Finance Home - My Yahoo - Yahoo! - Help

Monday, November 30, 2009, 12:06PM ET - U.S. Markets close in 3 hours and 54 minutes. Dow  0.35% Nasdaq  0.68%

Celgene Corporation (CELG)

At 11:51AM ET: 55.37   0.40 (0.73%)

MORE ON CELG

Quotes Summary Real-Time Options Historical Prices Charts Interactive Basic Chart Basic Tech. Analysis News & Info Headlines Financial Blogs Company Events Message Board Company Profile Key Statistics SEC Filings Competitors Industry Components Analyst Coverage Analyst Opinion Analyst Estimates Research Reports Star Analysts Ownership Major Holders Insider Transactions Insider Roster Financials Income Statement Balance Sheet Cash Flow

Headlines Get Headlines for:
Change Display [ hide $$  edit ] Today, Mon, Nov 30, 2009 • Johnson & Johnson: Good & Bad News at TheStreet.com (Mon 10:47am) • 13 Biotechs to Watch for at Hematology Conference at Seeking Alpha (Mon 4:47am) Fri, Nov 27, 2009 • Celgene Corporation to Present at the NASDAQ OMX 23rd Investor Program Business Wire (Fri, Nov 27) Wed, Nov 25, 2009 • Dream Stocks for Biotech Investors at Motley Fool (Wed, Nov 25) Mon, Nov 23, 2009 • Beware the Second Leg of the Next Great Recession at Motley Fool (Mon, Nov 23) Fri, Nov 20, 2009 • Yale Endowment Prefers ETFs, Selected Equities Indie Research (Fri, Nov 20) • Get Ready for a 25% Drop at Motley Fool (Fri, Nov 20) Thu, Nov 19, 2009 • [$$] Pinning Down Stock Prices Using Options at The Wall Street Journal Online (Thu, Nov 19) • Stocks You Can Be Thankful For at Motley Fool (Thu, Nov 19) • Now's a Great Time to Invest -- So Don't Blow It Like This at Motley Fool (Thu, Nov 19) Fri, Nov 13, 2009 • Celgene Corporation to Present at the Lazard Capital Markets 6th Annual Healthcare Conference Business Wire (Fri, Nov 13) Thu, Nov 12, 2009 • The Life-and-Death Situation That Isn't at Motley Fool (Thu, Nov 12) Wed, Nov 11, 2009 • Generic-Drug Makers Protest Supply Limits at The Wall Street Journal Online (Wed, Nov 11) • These Are the Market's 10 Best Stocks at Motley Fool (Wed, Nov 11) • More Than 200 Abstracts Evaluating Celgene Products across a Range of Indications to Be Presented at the 51st American Society of Hematology Meeting Business Wire (Wed, Nov 11) • Morgan Stanley's Nine Best Ideas at Seeking Alpha (Wed, Nov 11) Tue, Nov 10, 2009 • Top Large Cap Biotech Picks From UBS Research Wall Street Transcript (Tue, Nov 10) • Blood Cancer Meeting Abstracts Released: BioBuzz at TheStreet.com (Tue, Nov 10) • Bristol Licenses Arthritis Drug: BioBuzz at TheStreet.com (Tue, Nov 10) • Celgene in ASH Abstract Spotlight: BioBuzz at TheStreet.com (Tue, Nov 10) Older Headlines - Download Recent Headlines View headlines from: Tue, Nov 10, 2009Tue, Nov 3, 2009Tue, Oct 27, 2009Tue, Oct 20, 2009Tue, Oct 13, 2009Tue, Oct 6, 2009Tue, Sep 29, 2009Tue, Sep 22, 2009Tue, Sep 15, 2009Tue, Sep 8, 2009 Add CELG News to My Yahoo!:
Add to Portfolio     Set Alert     Email to a Friend Get Headlines for Another Symbol: Symbol Lookup • Stocks In Play • Story Stocks • Full Coverage